Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
CAS NO.6108-05-0
99%(1-10)Kilogram
6108-05-0 Good Supplier In China 6108-05-0 Linocaine hydrochloride
Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication. In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures. It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations. In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others. As a result, lidocaine is also considered a class Ib anti-arrhythmic agent. Nevertheless, lidocaine's local anesthetic action sees its use in many medical situations or circumstances that may benefit from its action, including the treatment of premature ejaculation
product Name | Lidocaine hydrochloride monohydrate |
---|---|
Synonyms | LIDOCAINE HCL monohydrate; 2-[(2,6-dimethylphenyl)amino]-N,N-diethyl-2-oxoethanaminium chloride hydrate (1:1:1); Linocaine Hydrochloride |
Molecular Formula | C 14 H 25 ClN 2 O 2 |
Molecular Weight | 288.8135 |
InChI | InChI=1/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2 |
CAS Registry Number | 6108-05-0 |
EINECS | 200-803-8 |
Molecular Structure | |
Boiling point | 350.8°C at 760 mmHg |
Flash point | 166°C |
Vapour Pressur | 4.28E-05mmHg at 25°C |